Leng, Bin <br/><br/>
Astragaloside IV improves vascular endothelial dysfunction by inhibiting the TLR4/NF-κB signaling pathway.  [electronic resource] 

 -  Life sciences  Sep 2018 
 - 111-121 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-0631 
<br/><br/><label>Standard No.: </label>10.1016/j.lfs.2018.07.053  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cytokines--metabolism<br/>Diabetes Mellitus, Experimental--complications<br/>Diabetic Angiopathies--etiology<br/>Endothelium, Vascular--drug effects<br/>Male<br/>NF-kappa B--antagonists & inhibitors<br/>Rats<br/>Rats, Sprague-Dawley<br/>Saponins--pharmacology<br/>Signal Transduction<br/>Toll-Like Receptor 4--antagonists & inhibitors<br/>Triterpenes--pharmacology